4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-19-011567
Chief Executive Officer sold 20,000 shares at $42.03 ($840,600)
- Chief Executive Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2019-04-29 | Option exercise | +20,000 | $1.81 | $36,200 | 186,542 | D |
| Kulkarni Samarth Chief Executive Officer | 2019-04-29 | Sale | −20,000 | $42.03 | $840,600 | 166,542 | D |
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2019-04-29 | Option exercise · Stock Option (Right to Buy) | −20,000 | 223,058 | D | ||
| Open-market sales · 20,000 sh · avg $42.03 · $840,600 | |||||||
Loading xslF345X03/doc4.xml…